Position in AMGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,318,841
-$4,466 QoQ
Shares Held
3,642
-3.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,518
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GUYASUTA INVESTMENT ADVISORS INC holds $53,362,618 across 9 Drug Manufacturers - General names. AMGN ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
102,689 | $26,079,925 | |
| 2 | MRK |
Merck & Co., Inc.
|
65,671 | $8,438,723 | |
| 3 | ABBV |
AbbVie Inc.
|
28,312 | $7,124,431 | |
| 4 | LLY |
ELI LILLY & Co
|
2,574 | $3,087,333 | |
| 5 | PFE |
Pfizer Inc
|
113,231 | $2,726,602 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,071 | $2,654,611 | |
| 7 | NVS |
Novartis AG
|
10,767 | $1,687,404 | |
| 8 | AMGN |
Amgen Inc
This page
|
3,642 | $1,318,841 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,318,841 | 3,642 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,323,307 | 3,761 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,229,376 | 3,756 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,058,532 | 3,751 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,045,641 | 3,745 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,158,966 | 3,720 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $978,703 | 3,755 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,207,965 | 3,749 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $962,970 | 3,082 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $876,274 | 3,082 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $887,677 | 3,082 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,067,514 | 3,972 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $881,863 | 3,972 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $922,518 | 3,816 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,002,234 | 3,816 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $734,578 | 3,259 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $797,780 | 3,279 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $767,778 | 3,175 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $714,279 | 3,175 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $675,163 | 3,175 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $787,312 | 3,230 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $791,215 | 3,180 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $731,145 | 3,180 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $723,085 | 2,845 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $600,263 | 2,545 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $505,000 | 2,491 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||